secwatch.observer — SEC 8-K summary
======================================

Issuer:     REGENEREX PHARMA, INC. (RGPX)
CIK:        0001357878
Form:       8-K
Filed at:   2025-11-12T23:59:59+00:00
Accession:  0001472375-25-000130
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03
LLM model:  deepseek-v4-flash:cloud@v2

Regenerex Pharma changes fiscal year end from March 31 to December 31
---------------------------------------------------------------------

- Board approved fiscal year change effective September 22, 2025.
- New fiscal year end will be December 31, replacing March 31.
- Transition report on Form 10-K for April 1, 2025 to December 31, 2025 to be filed.
- No other amendments to bylaws or articles were disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000130/0001472375-25-000130-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357878/000147237525000130/ixform8k.htm
  HTML page:      https://secwatch.observer/filing/0001472375-25-000130

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer